• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday

    8/2/22 5:01:37 AM ET
    $AEMD
    $AJRD
    $ALRN
    $AMTD
    Medical/Dental Instruments
    Health Care
    Military/Government/Technical
    Industrials
    Get the next $AEMD alert in real time by email

    Gainers

    • Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) climbed 119.4% to settle at $11.85 on Monday after declining 74% on Friday.
    • Ontrak, Inc. (NASDAQ:OTRK) shares jumped 107.7% to close at $1.35 on Monday. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.
    • Revlon, Inc. (NYSE:REV) gained 89.9% to close at $8.49 following a Reuters report suggesting a US bankruptcy judge has given the company permission to proceed with a $1.4 billion loan.
    • AMTD Digital Inc. (NYSE:HKD) rose 85.4% to settle at $742.00 on continued upward volatility following the stock's July IPO.
    • MediaCo Holding Inc. (NASDAQ:MDIA) shares gained 60.9% to close at $3.33. MediaCo Holding 10% owner Soohyung Kim bought a total of 12,899,480 shares at an average price of $2.32.
    • Nanobiotix S.A. (NASDAQ:NBTX) rose 47% to close at $3.41.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) gained 42.9% to close at $3.90 amid continued strength in monkeypox names. The company also recently announced the publication of a peer-reviewed animal efficacy study of its modified vaccine Ankara vectored vaccine against Sudan ebolavirus.
    • Celyad Oncology SA (NASDAQ:CYAD) gained 40.8% to close at $2.45 after the company said that the FDA has lifted the clinical hold on the CYAD-101-002 (KEYNOTE-B79) Phase 1b trial.
    • Aethlon Medical, Inc. (NASDAQ:AEMD) jumped 38% to settle at $1.38 after dropping over 7% on Friday.
    • TherapeuticsMD, Inc. (NASDAQ:TXMD) jumped 36.6% to close at $8.51 after the company announced it has received a $15 million private investment from Rubric Capital Management.
    • MAIA Biotechnology, Inc. (NASDAQ:MAIA) gained 34.5% to close at $7.80 after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00 per share.
    • Performance Shipping Inc. (NASDAQ:PSHG) surged 30.9% to settle at $0.36. Performance Shipping recently entered into a time charter contract with Teekay Chartering Limited, with a gross charter rate of $23,000 per day for a period of roughly 24 months.
    • Reed's, Inc. (NASDAQ:REED) jumped 30% to close at $0.2049.
    • Romeo Power, Inc. (NYSE:RMO) gained 26.9% to close at $0.6981 after Nikola announced it will acquire the company in an all-stock transaction for an implied consideration of $0.74 per share.
    • Outset Medical, Inc. (NASDAQ:OM) gained 26.9% to close at $19.61 after the company announced the resumption of Tablo Hemodialysis System shipments for home use.
    • Sientra, Inc. (NASDAQ:SIEN) rose 25.9% to close at $0.9313.
    • Better Therapeutics, Inc. (NASDAQ:BTTX) surged 24.8% to settle at $2.77. Better Therapeutics recently completed its clinical trial for BT-001, an investigational prescription digital therapeutic that is designed to use nCBT to treat type 2 diabetes.
    • EVO Payments, Inc. (NASDAQ:EVOP) gained 23.3% to close at $33.71 after Global Payments entered an agreement to acquire the company for $34 per share in cash.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) rose 21.9% to settle at $8.64 after the company announced it has started to sell 93 of its products on Amazon Italy and Amazon Germany.
    • Twin Vee Powercats Co. (NASDAQ:VEEE) jumped 20.7% to settle at $3.50.
    • LiveVox Holdings, Inc. (NASDAQ:LVOX) gained 20.6% to close at $1.99.
    • Stealth BioTherapeutics Corp (NASDAQ:MITO) rose 19.9% to close at $0.29 after the company announced it has entered into a definitive agreement for a going private transaction.
    • TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) climbed 19.5% to close at $1.04 after dropping over 9% on Friday.
    • Sierra Wireless, Inc. (NASDAQ:SWIR) gained 19.4% to close at $29.70 following a Bloomberg report suggesting Semtech is said to be in advanced talks to acquire the company.
    • Getty Images Holdings, Inc. (NASDAQ:GETY) climbed 18.9% to settle at $31.10 on continued strength after the stock surged last week following the redemption of nearly 99.4% of shares by CCNB shareholders.
    • Lottery.com Inc. (NASDAQ:LTRY) rose 18.7% to close at $0.3501. Lottery.com shares tumbled around 64% on Friday after the company in an SEC filing said its board determined it does not have sufficient financial resources to fund operations.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) gained 18.5% to settle at $29.40 on continued volatility after the company completed its SPAC merger agreement in June.
    • AMTD IDEA Group (NYSE:AMTD) climbed 18.2% to close at $2.08.
    • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) rose 17.9% to close at $0.75.
    • Surrozen, Inc. (NASDAQ:SRZN) rose 17.7% to settle at $3.00.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) gained 16.3% to close at $5.07 after declining around 15% on Friday.
    • Cadiz Inc. (NASDAQ:CDZI) jumped 16.1% to settle at $4.40.
    • Inseego Corp. (NASDAQ:INSG) gained 16.1% to close at $2.59.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) shares rose 16% to close at $12.98 on post-IPO volatility following Friday's IPO, which was priced at $4 per share.
    • Bridgford Foods Corporation (NASDAQ:BRID) gained 14.8% to close at $14.58.
    • Pearson plc (NYSE:PSO) gained 13.5% to close at $10.51 as the company backed its full-year profit guidance.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) rose 13.1% to close at $34.00.
    • Volta Inc. (NYSE:VLTA) gained 13% to close at $2.08.
    • Rite Aid Corporation (NYSE:RAD) rose 12.1% to close at $9.23 amid speculation of activist interest.
    • Celsius Holdings, Inc. (NASDAQ:CELH) gained 11.1% to close at $98.87 after the company announced a long-term strategic distribution arrangement with PepsiCo, which will also make an investment in Celsius.
    • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) rose 10.7% to close at $1.86 after dropping 10% on Friday. Tonix Pharmaceuticals recently announced a collaboration with the Kenya Medical Research Institute to plan, seek regulatory approval for and conduct a Phase 1 clinical study to develop TNX-801 as a vaccine to protect against monkeypox and smallpox.
    • 36Kr Holdings Inc. (NASDAQ:KRKR) rose 10.4% to close at $1.27 after gaining more than 9% on Friday.
    • Roku, Inc. (NASDAQ:ROKU) gained 9.4% to close at $71.69. Morgan Stanley maintained Roku with an Underweight and lowered the price target from $80 to $55.
    • HSBC Holdings plc (NYSE:HSBC) surged 6.5% to settle at $33.44 after the company reported Q2 earnings results.
    • The Boeing Company (NYSE:BA) gained 6.1% to close at $169.07 following a report suggesting the FAA approved the company's inspection and modification plan to resume deliveries of the 787.
    • Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) gained 5.2% to close at $27.66 following Q2 results.
    • PerkinElmer, Inc. (NYSE:PKI) gained 5% to close at $160.87 after the company reported better-than-expected Q2 financial results, issued Q3 guidance above estimates and raised its FY22 guidance above estimates. The company also announced it will divest its Applied, Food and Enterprise Services businesses to New Mountain Capital for total consideration of $2.45 billion in cash.
    • Li Auto Inc. (NASDAQ:LI) gained 3.8% to close at $34.10 after the company announced it delivered 10,422 Li ONEs in July 2022, up 21.3% year over year.


    Losers

    • Otonomy, Inc. (NASDAQ:OTIC) shares dipped 79.6% to close at $0.2913 on Monday after the company announced it will discontinue development of OTO-313 after the Phase 2 trial of OTO-313 in patients with tinnitus demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints.
    • Kazia Therapeutics Limited (NASDAQ:KZIA) shares fell 47% to close at $1.92 after the company announced its GBM AGILE pivotal study for paxalisib did not meet the pre-defined criteria for continuing to a second stage.
    • Zovio Inc (NASDAQ:ZVO) fell 35% to close at $0.67 as the company reported a second-quarter FY22 sales decline of 25.7% year-on-year, to $51.38 million.
    • Xinyuan Real Estate Co., Ltd. (NYSE:XIN) fell 33.4% to close at $0.4801. Xinyuan Real Estate recently received letter from NYSE on listing compliance.
    • Tuniu Corporation (NASDAQ:TOUR) fell 23.5% to close at $0.8879.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) dropped 21.8% to close at $0.5911.
    • F45 Training Holdings Inc. (NYSE:FXLV) declined 21.3% to close at $1.55.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) dropped 20.9% to close at $2.65.
    • Bright Green Corporation (NASDAQ:BGXX) dropped 20% to settle at $1.32.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) fell 19.9% to close at $1.17.
    • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) dipped 19.8% to close at $0.77.
    • I-Mab (NASDAQ:IMAB) fell 18.6% to close at $8.53.
    • Mercurity Fintech Holding Inc. (NASDAQ:MFH) dipped 17.8% to close at $0.7456.
    • Omega Therapeutics, Inc. (NASDAQ:OMGA) fell 16.7% to close at $4.25. The U.S. Food and Drug Administration (FDA) recently announced clearance to Omega Therapeutics’ Investigational New Drug (IND) to initiate a Phase 1/2 clinical study of its candidate OTX-2002 for the treatment of hepatocellular carcinoma (HCC).
    • Holley Inc. (NYSE:HLLY) dropped 16.5% to close at $6.67. Raymond James maintained Holley with an Outperform and lowered the price target from $14 to $10.
    • Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) dropped 16.5% to close at $20.26. The FDA approved Arcutis Biotherapeutics’ Zoryve (roflumilast) cream 0.3% for plaque psoriasis, including intertriginous areas, in patients 12 years of age or older.
    • Uxin Limited (NASDAQ:UXIN) fell 16.2% to close at $0.5910. Uxin recently posted Q4 earnings of $0.05 per share.
    • Aileron Therapeutics, Inc. (NASDAQ:ALRN) dropped 16.2% to settle at $0.1602. Aileron Therapeutics outlined strategy to strengthen Phase 1b clinical trial of ALRN-6924 IN PATIENTS WITH p53-mutated breast cancer.
    • HilleVax, Inc. (NASDAQ:HLVX) dipped 15.9% to settle at $11.37.
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) dipped 15.6% to close at $ 1.41.
    • BiomX Inc. (NYSE:PHGE) fell 15.2% to close at $0.7609 after dropping 16% on Friday.
    • Scienjoy Holding Corporation (NASDAQ:SJ) dipped 15.2% to close at $4.52.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) declined 13.8% to close at $0.2320 after jumping 27% on Friday.
    • JELD-WEN Holding, Inc. (NYSE:JELD) dipped 13.7% to close at $15.34 after the company posted downbeat Q2 earnings and lowered FY22 forecast.
    • Reliance Global Group, Inc. (NASDAQ:RELI) dropped 13.5% to settle at $0.82.
    • Missfresh Limited (NASDAQ:MF) dipped 13.1% to close at $0.10. Missfresh recently announced adjustments to its business strategy, which will have an adverse impact on its financial performance.
    • Planet Green Holdings Corp. (NYSE:PLAG) dropped 11.3% to close at $0.86.
    • TuSimple Holdings Inc. (NASDAQ:TSP) fell 9.7% to close at $8.99. The accident of an autonomously driven truck fitted with technology by TuSimple Holdings on April 6 has triggered concerns over risking safety on public roads, the Wall Street Journal reported.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) fell 9.3% to close at $2.84.
    • Q&K International Group Limited (NASDAQ:QK) fell 8.8% to settle at $1.96.
    • Innate Pharma S.A. (NASDAQ:IPHA) fell 8.5% to close at $2.81 after the company issued an update on AstraZeneca-sponsored INTERLINK-1 Phase 3 study. The company said the study did not meet pre-defined threshold for efficacy and will be discontinued.
    • Royal Caribbean Cruises Ltd. (NYSE:RCL) fell 7.5% to close at $35.79 after the company announced a private offering of senior convertible notes in an aggregate principal amount of up to $900 million.
    • Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD) dipped 7.3% to close at $40.52 after the company reported worse-than-expected Q2 EPS and sales results.
    • iQIYI, Inc. (NASDAQ:IQ) dropped 7.1% to close at $3.55. Shares of Chinese companies traded lower after July factory activity pulled back from June levels.
    Get the next $AEMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEMD
    $AJRD
    $ALRN
    $AMTD

    CompanyDatePrice TargetRatingAnalyst
    Celsius Holdings Inc.
    $CELH
    2/27/2026$65.00Underperform → Buy
    BofA Securities
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Surrozen Inc.
    $SRZN
    2/19/2026$40.00Overweight
    Cantor Fitzgerald
    Roku Inc.
    $ROKU
    2/13/2026$118.00Neutral → Buy
    Rosenblatt
    Li Auto Inc.
    $LI
    2/9/2026$14.00Neutral → Underweight
    Analyst
    Nanobiotix S.A.
    $NBTX
    2/6/2026Buy
    TD Cowen
    Roku Inc.
    $ROKU
    2/6/2026$105.00Perform → Outperform
    Oppenheimer
    CADIZ Inc.
    $CDZI
    2/2/2026$10.00Buy
    Maxim Group
    More analyst ratings

    $AEMD
    $AJRD
    $ALRN
    $AMTD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Swets Larry G Jr bought $47,000 worth of shares (100,000 units at $0.47) (SEC Form 4)

    4 - Twin Vee PowerCats, Co. (0001855509) (Issuer)

    2/25/26 5:02:06 PM ET
    $VEEE
    Marine Transportation
    Industrials

    CEO & Interim CFO Visconti Joseph C bought $9,400 worth of shares (20,000 units at $0.47), increasing direct ownership by 8% to 262,914 units (SEC Form 4)

    4 - Twin Vee PowerCats, Co. (0001855509) (Issuer)

    2/25/26 5:01:09 PM ET
    $VEEE
    Marine Transportation
    Industrials

    Large owner Tcg Crossover Gp Ii, Llc bought $444,844 worth of shares (18,856 units at $23.59) (SEC Form 4)

    4 - Surrozen, Inc./DE (0001824893) (Issuer)

    2/13/26 4:19:53 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEMD
    $AJRD
    $ALRN
    $AMTD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZORYVE issued to ARCUTIS BIOTHERAPEUTICS INC

    Submission status for ARCUTIS BIOTHERAPEUTICS INC's drug ZORYVE (ORIG-1) with active ingredient ROFLUMILAST has changed to 'Approval' on 12/15/2023. Application Category: NDA, Application Number: 217242, Application Classification: Type 3 - New Dosage Form

    12/19/23 3:40:08 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZORYVE issued to ARCUTIS BIOTHERAPEUTICS INC

    Submission status for ARCUTIS BIOTHERAPEUTICS INC's drug ZORYVE (ORIG-1) with active ingredient ROFLUMILAST has changed to 'Approval' on 12/15/2023. Application Category: NDA, Application Number: 217242, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    12/15/23 5:01:31 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $AJRD
    $ALRN
    $AMTD
    SEC Filings

    View All

    Royal Caribbean Cruises Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Filer)

    2/27/26 4:30:45 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    SEC Form 10-K filed by Twin Vee PowerCats Co.

    10-K - Twin Vee PowerCats, Co. (0001855509) (Filer)

    2/27/26 4:09:22 PM ET
    $VEEE
    Marine Transportation
    Industrials

    SEC Form 20-F filed by AMTD Digital Inc.

    20-F - AMTD Digital Inc. (0001809691) (Filer)

    2/27/26 4:03:50 PM ET
    $HKD
    Finance: Consumer Services
    Finance

    $AEMD
    $AJRD
    $ALRN
    $AMTD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Celsius upgraded by BofA Securities with a new price target

    BofA Securities upgraded Celsius from Underperform to Buy and set a new price target of $65.00

    2/27/26 8:20:43 AM ET
    $CELH
    Beverages (Production/Distribution)
    Consumer Staples

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cantor Fitzgerald initiated coverage on Surrozen with a new price target

    Cantor Fitzgerald initiated coverage of Surrozen with a rating of Overweight and set a new price target of $40.00

    2/19/26 7:52:22 AM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEMD
    $AJRD
    $ALRN
    $AMTD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    With TGE Consolidated, AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD Digital Inc. ("AMTD Digital" or the "Company") (NYSE:HKD), a NYSE-listed company and a subsidiary of AMTD Group Inc., today announced the filing of its annual report on Form 20-F for the fiscal year ended October 31, 2025 with the Securities and Exchange Commission, which consolidates the financial results of The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE);  summary highlights below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounte

    2/27/26 4:28:00 PM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    AMTD IDEA's Subsidiary AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD IDEA (NYSE:AMTD, SGX: HKB)) subsidiary AMTD Digital Inc. (NYSE:HKD), a NYSE‑listed company and subsidiary of AMTD Group Inc., today announced it has filed its annual report on Form 20‑F with the U.S. Securities and Exchange Commission for the fiscal year ended October 31, 2025. Summary highlights are below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounted to US$603.7 million (US$4.78/share)The annual report is available on AMTD Digital's investor

    2/27/26 4:27:00 PM ET
    $AMTD
    $HKD
    Finance: Consumer Services
    Finance

    AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD Digital Inc. ("AMTD Digital" or the "Company") (NYSE:HKD), a NYSE-listed company and a subsidiary of AMTD Group Inc., today announced the filing of its annual report on Form 20-F for the fiscal year ended October 31, 2025 with the Securities and Exchange Commission, with summary highlights below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounted to US$603.7 million (US$4.78/share)The annual report is available on the Company's investor relations w

    2/27/26 4:25:00 PM ET
    $HKD
    Finance: Consumer Services
    Finance

    $AEMD
    $AJRD
    $ALRN
    $AMTD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wilhelmsen Arne Alexander sold $243,570,580 worth of shares (771,607 units at $315.67) (SEC Form 4)

    4 - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Issuer)

    2/27/26 5:01:55 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    EVP, Gov Ops, GPP & CS Shockey Jeffrey S covered exercise/tax liability with 4,444 shares, decreasing direct ownership by 16% to 23,294 units (SEC Form 4)

    4 - BOEING CO (0000012927) (Issuer)

    2/26/26 7:27:49 PM ET
    $BA
    Aerospace
    Industrials

    EVP and Chief HR Officer Amuluru Uma M sold $351,484 worth of shares (1,503 units at $233.78), decreasing direct ownership by 7% to 19,015 units (SEC Form 4)

    4 - BOEING CO (0000012927) (Issuer)

    2/26/26 7:21:47 PM ET
    $BA
    Aerospace
    Industrials

    $AEMD
    $AJRD
    $ALRN
    $AMTD
    Financials

    Live finance-specific insights

    View All

    Li Auto Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

    BEIJING, China, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced that it will report its unaudited financial results for the fourth quarter and full year 2025 before the U.S. market opens on Thursday, March 12, 2026. The Company's management will hold an earnings conference call on Thursday, March 12, 2026, at 8:00 A.M. U.S. Eastern Time or 8:00 P.M. Beijing/Hong Kong Time on the same day. For participants who wish to join the call, please complete online registration using the link provided below prior to the scheduled call start time. Upon registration, participants will

    2/27/26 4:00:00 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Celsius Holdings Reports Full-Year 2025 and Fourth Quarter Financial Results

    Record annual revenue of $2.5 billion reflects scale and disciplined growth in fast-growing energy category Strategic energy leadership and portfolio integration within PepsiCo system positions company for sustainable growth Celsius Holdings' portfolio contributed 33% of the zero-sugar l U.S. energy category's $3.3 billion growth in 20251 Celsius Holdings, Inc. (NASDAQ:CELH) ("Celsius Holdings" or "the company") today reported fourth quarter and full-year 2025 financial results. Summary of Fourth Quarter and Full-Year 2025 Financial Results Summary Financials 4Q 2025   4Q 2024   Change FY 2025 FY 2024 Change   (Milli

    2/26/26 6:00:00 AM ET
    $CELH
    Beverages (Production/Distribution)
    Consumer Staples

    iQIYI Announces Fourth Quarter and Fiscal Year 2025 Financial Results

    BEIJING, China, Feb. 26, 2026 (GLOBE NEWSWIRE) -- iQIYI, Inc. (NASDAQ:IQ) ("iQIYI" or the "Company"), a leading provider of online entertainment video services in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025.          Fourth Quarter 2025 Highlights Total revenues were RMB6.79 billion (US$971.6 million1), increasing 3% year over year.Operating income was RMB55.4 million (US$7.9 million) and operating income margin was 1%, compared to operating income of RMB285.4 million and operating income margin of 4% in the same period in 2024.Non-GAAP operating income2 was RMB143.5 million (US$20.5 million) and non-GAAP operating

    2/26/26 4:00:00 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $AEMD
    $AJRD
    $ALRN
    $AMTD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by CADIZ Inc.

    SC 13G/A - CADIZ INC (0000727273) (Subject)

    12/6/24 6:52:25 PM ET
    $CDZI
    Water Supply
    Utilities

    Amendment: SEC Form SC 13D/A filed by Reeds Inc.

    SC 13D/A - REED'S, INC. (0001140215) (Subject)

    12/6/24 4:30:32 PM ET
    $REED

    Amendment: SEC Form SC 13D/A filed by Tuniu Corporation

    SC 13D/A - Tuniu Corp (0001597095) (Subject)

    12/6/24 6:30:27 AM ET
    $TOUR
    Transportation Services
    Consumer Discretionary

    $AEMD
    $AJRD
    $ALRN
    $AMTD
    Leadership Updates

    Live Leadership Updates

    View All

    Pearson 2025 Preliminary Results (Unaudited)

    Confident in outlook, guiding to mid-single digit sales growth for 2026 and beyond. Strong financial position, with £350m share buyback well underway. LONDON, Feb. 27, 2026 /PRNewswire/ -- Financial Highlights£m2025vs 2024£m20252024Business performanceStatutory resultsSales3,577+4%1Sales3,5773,552Adjusted operating profit614+6%1Operating profit507541Operating cash flow571-14%2Profit for the period336435Free cash flow527+8%2Net cash generated from operations   731811Adjusted earnings per share   64.5p+4%2Basic earnings per share51.4p64.5pHighlightsUnderlying Group sales growth of

    2/27/26 2:06:00 AM ET
    $PSO
    Books
    Consumer Discretionary

    Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

    Aethlon invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference.SAN DIEGO, Feb. 23, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 25, 2026 at 12:30-1:00 PM ET. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO and CFO, Jim Frakes in

    2/23/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Royal Caribbean Group Appoints Christopher J. Wiernicki to Board of Directors

    MIAMI, Feb. 17, 2026 /PRNewswire/ -- Royal Caribbean Group (NYSE:RCL) today announced the appointment of Christopher J. Wiernicki, former Chairman & CEO, American Bureau of Shipping (ABS), to its Board of Directors, effective immediately. Wiernicki brings more than four decades of commercial, government and international experience in marine and offshore design, along with operations, infrastructure and safety management, ports and bunkering, digitalization, cyber security, and clean energy transition expertise.During his fourteen-year tenure at the helm of ABS, a global leader

    2/17/26 8:27:00 AM ET
    $RCL
    Marine Transportation
    Consumer Discretionary